JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wieland, H. A.
Right arrow Articles by Doods, H. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wieland, H. A.
Right arrow Articles by Doods, H. N.

Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226

HA Wieland, KD Willim, M Entzeroth, W Wienen, K Rudolf, W Eberlein, W Engel and HN Doods

Preclinical Research Department, Dr. Karl Thomae GmbH, Biberach, Germany.

In the present study, the subtype specificity and species selectivity of the nonpeptide BIBP 3226, as well as its in vitro antagonism of neuropeptide Y (NPY)-mediated second messengers have been investigated. Radiolabeled NPY is potently displaced by BIBP 3226 [(R)-N2- (diphenylacetyl)-N-[(4-hydroxyphenylmethyl]-D- arginine amide] on human Y1 receptor expressing Chinese hamster ovary-K1 cells (Ki = 0.47 +/- 0.07 nM). SK-N-MC human neuroblastoma cells (Ki = 5.1 +/- 0.5 nM) and the rat parietal cortex membranes (Ki = 6.8 +/- 0.7 nM). The interaction of BIBP 3226 with the Y1 receptor is stereoselective, because the (S)-enantiomer of the (R)-configured BIBP 3226 displays almost no affinity (Ki > 10,000 nM). In contrast, concentrations up to 10 microM BIBP 3226 do not displace [125I]NPY from the human Y2 receptor (neuroblastoma cell line SMS-KAN), the rabbit Y2 receptor (kidney) and the rat Y2 receptor (hippocampus). Functional antagonism could be shown for the human Y1 receptor: 0.1 microM BIBP 3226 antagonizes the NPY induced Ca++ mobilization (pKb = 7.5 +/- 0.17) as well as the NPY-mediated inhibition of cyclic AMP synthesis (pKb = 8.2 +/- 0.24) in SK-N-MC cells. In contrast, none of the formerly described putative antagonists PYX-2, [D-Trp32]NPY and benextramine could be characterized as high affinity Y1 receptor antagonists. The 18 amino acid NPY analog EXBP 68 Ile-Glu-Pro-Orn-Tyr-Arg-Leu-Arg-Tyr-NH2, cyclic (2,4'), (2',4')-diamide] displayed Y1-selective affinity with in vitro antagonistic properties (Ki = 0.33 +/- 0.04 nM and pKb = 8.4 +/- 0.07) in SK-N-MC cells. Therefore, BIBP 3226 is the first potent and subtype- selective nonpeptide Y1 receptor antagonist.

Volume 275, Issue 1, pp. 143-149, 10/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
EndocrinologyHome page
E. L. Dimitrov, M. R. DeJoseph, M. S. Brownfield, and J. H. Urban
Involvement of Neuropeptide Y Y1 Receptors in the Regulation of Neuroendocrine Corticotropin-Releasing Hormone Neuronal Activity
Endocrinology, August 1, 2007; 148(8): 3666 - 3673.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Misra, K. S. Murthy, H. Zhou, and J. R. Grider
Coexpression of Y1, Y2, and Y4 Receptors in Smooth Muscle Coupled to Distinct Signaling Pathways
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1154 - 1162.
[Abstract] [Full Text] [PDF]


Home page
Chem SensesHome page
W. B. Floriano, N. Vaidehi, and W. A. Goddard III
Making Sense of Olfaction through Predictions of the 3-D Structure and Function of Olfactory Receptors
Chem Senses, May 1, 2004; 29(4): 269 - 290.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. R. Grider and L. E. Langdon
Physiological role of neuropeptide Y in the regulation of the ascending phase of the peristaltic reflex
Am J Physiol Gastrointest Liver Physiol, December 1, 2003; 285(6): G1139 - G1146.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. C. Yannielli and M. E. Harrington
The Neuropeptide Y Y5 Receptor Mediates the Blockade of "Photic-Like" NMDA-Induced Phase Shifts in the Golden Hamster
J. Neurosci., July 15, 2001; 21(14): 5367 - 5373.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Xu, J. H. Urban, J. W. Hill, and J. E. Levine
Regulation of Hypothalamic Neuropeptide Y Y1 Receptor Gene Expression during the Estrous Cycle: Role of Progesterone Receptors
Endocrinology, September 1, 2000; 141(9): 3319 - 3327.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Hoyo, J. C. McGrath, and E. Vila
Evidence for Y1-Receptor-Mediated Facilitatory, Modulatory Cotransmission by NPY in the Rat Anococcygeus Muscle
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 38 - 44.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. Renshaw, L. M. Thomson, M. Carroll, S. Kapas, and J. P. Hinson
Actions of Neuropeptide Y on the Rat Adrenal Cortex
Endocrinology, January 1, 2000; 141(1): 169 - 173.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Iyengar, D. L. Li, and R. M. A. Simmons
Characterization of Neuropeptide Y-Induced Feeding in Mice: Do Y1-Y6 Receptor Subtypes Mediate Feeding?
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1031 - 1040.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
L. Sun and R. J. Miller
Multiple Neuropeptide Y Receptors Regulate K+ and Ca2+ Channels in Acutely Isolated Neurons From the Rat Arcuate Nucleus
J Neurophysiol, March 1, 1999; 81(3): 1391 - 1403.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P.-O. Carlsson, A. Andersson, and L. Jansson
Influence of age, hyperglycemia, leptin, and NPY on islet blood flow in obese-hyperglycemic mice
Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E594 - E601.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Dumont, A. Fournier, and R. Quirion
Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain
J. Neurosci., August 1, 1998; 18(15): 5565 - 5574.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. L. Parker, M. S. Parker, T. Sweatman, and W. R. Crowley
Characterization of G Protein and Phospholipase C-Coupled Agonist Binding to the Y1 Neuropeptide Y Receptor in Rat Brain: Sensitivity to G Protein Activators and Inhibitors and to Inhibitors of Phospholipase C
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 382 - 391.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
M. C. Michel, A. Beck-Sickinger, H. Cox, H. N. Doods, H. Herzog, D. Larhammar, R. Quirion, T. Schwartz, and T. Westfall
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
Pharmacol. Rev., March 1, 1998; 50(1): 143 - 150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Han, C.-L. Yang, X. Chen, L. Naes, B. F. Cox, and T. Westfall
Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction
Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H290 - H294.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Rhim, G. A. Kinney, P. J. Emmerson, and R. J. Miller
Regulation of Neurotransmission in the Arcuate Nucleus of the Rat by Different Neuropeptide Y Receptors
J. Neurosci., May 1, 1997; 17(9): 2980 - 2989.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.